Nomogram for predicting PCa recurrence is validated


New York-A computer model nomogram that uses three preoperative prostate cancer variables to predict probabilities for cancer recurrence within 5 years has been successfully validated. The nomogram will not only aid physicians in making treatment decisions, but it could also help improve patients' ability to make decisions about their treatment, according to researchers from Memorial Sloan-Kettering Cancer Center in New York.

Related Videos
Heather L. Huelster, MD, answers a question during a Zoom video interview
3d rendered illustration of kidney cancer | Image Credit: © SciePro -
Bottle of white pills | Image Credit: © leighannef -
A panel of 5 experts on prostate cancer
A panel of 5 experts on prostate cancer
Illustration of AI | Image Credit: © Tierney -
Related Content
© 2023 MJH Life Sciences

All rights reserved.